| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.005 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |